NCT01936571
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- MAASTRO clinic Maastricht, Limburg, Netherlands
Clinical trial condition
Carcinoma, Non-Small-Cell Lung
Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.
4,696 public trials
1,038 recruiting studies
Carcinoma, Non-Small-Cell Lung trial results
NCT00898820
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT01000480
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Le Mans, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lyon, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montpellier, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France
Completed
Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
NCT00085280
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Eastern Cooperative Oncology Group Boston, Massachusetts, United States
Completed
NSCLC Burden of Illness Study
NCT01772225
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
NCT00730925
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- 1200.41.32003 Boehringer Ingelheim Investigational Site Antwerp, Belgium
- 1200.41.32007 Boehringer Ingelheim Investigational Site Charleroi, Belgium
- 1200.41.32001 Boehringer Ingelheim Investigational Site Jette, Belgium
- 1200.41.32011 Boehringer Ingelheim Investigational Site Leuven, Belgium
NCT01106781
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Research Site Beijing, Beijing Municipality, China
- Research Site Chongqing, Chongqing Municipality, China
- Research Site Guangzhou, Guangdong, China
- Research Site Wuhan, Hubei, China
Completed
Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer
NCT00247416
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Commonwealth Cancer Center Danville, Kentucky, United States
- Markey Cancer Center Lexington, Kentucky, United States
- Brown Cancer Center Louisville, Kentucky, United States
- St. Claire Regional Medical Center Morehead, Kentucky, United States
NCT00476216
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
NCT00538850
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +260 more
- Locations
-
- InSys Therapeutics, Incorporated Chandler, Arizona, United States